← Back to Clinical Trials
Recruiting NCT05608694
NCT05608694 MRI Screening in Men at High Risk of Developing Prostate Cancer
◆ AI Clinical Summary
Plain-language summary for patients
| NCT ID | NCT05608694 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Chicago |
| Condition | Prostate Cancer Screening |
| Study Type | INTERVENTIONAL |
| Enrollment | 250 participants |
| Start Date | 2022-03-02 |
| Primary Completion | 2037-03-01 |
Trial Parameters
Condition Prostate Cancer Screening
Sponsor University of Chicago
Study Type INTERVENTIONAL
Phase N/A
Enrollment 250
Sex MALE
Min Age 18 Years
Max Age N/A
Start Date 2022-03-02
Completion 2037-03-01
Interventions
Prostate MRI
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
Brief Summary
The purpose of this study is to determine whether or not Magnetic Resonance Images (MRI) will identify high-grade cancers earlier and more frequently in men at high risk of developing prostate cancer.
Eligibility Criteria
Inclusion Criteria: * Male age 18 and older * No known history of prostate cancer * No previous prostate resection or ablation (e.g. TURP, photovaporization) Exclusion Criteria: * Unable to tolerate MRI due to metal fragments or claustrophobia * Lack of a rectum * Hip arthroplasty
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: April 2026 · Data Methodology